The effects of serine palmitoyltransferase inhibitor, ISP-I, on uv-induced barrier disruption in the stratum corneum

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 12, 2010, Pages 2008-2012

  Mizukoshi, Koji ^a   Oshima, Hiroshi ^a   Matsumoto, Katsuo ^a   Hirose, Ryouji ^b   Fujita, Tetsuro ^c  

^a POLA CHEMICAL INDUSTRIES INC   (Japan)

^b Shin Mitsui Sugar Co Ltd   (Japan)

^c RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

Author keywords

Ceramide; ISP I (myriocin); Serine palmitoyltransferase; Skin barrier; UVB

Indexed keywords

CERAMIDE; THERMOZYMOCIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; LIPOGENESIS; MEMBRANE DAMAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; RADIATION EXPOSURE; RADIATION INJURY; SKIN FUNCTION; SKIN INJURY; SKIN PROTECTION; SKIN WATER LOSS; STRATUM CORNEUM; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; ASCOMYCOTA; BIOLOGICAL PRODUCTS; CELL PROLIFERATION; CERAMIDES; EPIDERMIS; FATTY ACIDS, MONOUNSATURATED; FEMALE; MICE; MICE, HAIRLESS; SERINE C-PALMITOYLTRANSFERASE; WATER;

EID: 78751550119     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.2008     Document Type: Article

References (26)

1. Elias P. M., Feingold K. R., Semin. Dermatol., 11, 176-182 (1992).
2. Geilen C. C., Barz S., Bektas M., Skin Pharmacol. Appl. Skin Physiol., 14, 261-271 (2001).
3. Wakita H., Tokura Y., Yagi H., Nishimura K., Furukawa F., Takigawa M., Arch. Dermatol. Res., 286, 350-354 (1994).
4. Takeda S., Mitsutake S., Tsuji K., Igarashi Y., J. Biochem., 139, 255-262 (2006).
5. Ruvolo P. P., Leukemia, 15, 1153-1160 (2001).
6. Hanada K., Biochim. Biophys. Acta, 1632, 16-30 (2003).
7. Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., Chiba K., Hoshino Y., Okumoto T., J. Antibiot. (Tokyo), 47, 208-215 (1994).
8. Kluepfel D., Bagli J., Baker H., Charest M. P., Kudelski A., J. Antibiot. (Tokyo), 25, 109-115 (1972).
9. St-Jacques M., J. Org. Chem., 38, 1253-1260 (1973).
10. Craveri R., Manachini P. L., Aragozzini F., Experientia, 28, 867-868 (1972).
11. Aragozzini F, Manachini P. L., Craveri R., Rindone B., Scolastico C., Tetrahedron, 28, 5493-5498 (1972).
12. Miyake Y., Kozutsumi Y., Nakamura S., Fujita T., Kawasaki T., Biochem. Biophys. Res. Commun., 211, 396-403 (1995).
13. Yang L., Mao-Qiang M., Taljebini M., Elias P. M., Feingold K. R., Br. J. Dermatol., 133, 679-685 (1995).
14. Holleran W. M., Man M. Q., Gao W. N., Menon G. K., Elias P. M., Feingold K. R., J. Clin. Invest., 88, 1338-1345 (1991).
15. Haratake A., Uchida Y., Schmuth M., Tanno O., Yasuda R., Epstein J. H., Elias P. M., Holleran W. M., J. Invest. Dermatol., 108, 769-775 (1997).
16. Kane K. S., Maytin E. V., J. Invest. Dermatol., 104, 62-67 (1995).
17. Hanada K., Nishijima M., Fujita T., Kobayashi S., Biochem. Pharmacol., 59, 1211-1216 (2000).
18. Nakano R., Tsuyama S., Murata F., J. Dermatol. Sci., 14, 54-62 (1997).
19. Kitano Y., Okada N., Br. J. Dermatol., 108, 555-560 (1983).
20. Behne M., Uchida Y., Seki T., de Montellano P. O., Elias P. M., Holleran W. M., J. Invest. Dermatol., 114, 185-192 (2000).
21. Ya-Xian Z., Suetake T., Tagami H., Arch. Dermatol. Res., 291, 555-559 (1999).
22. Lavrijsen A. P., Bouwstra J. A., Gooris G. S., Weerheim A., Boddé H. E., Ponec M., J. Invest. Dermatol., 105, 619-624 (1995).
23. Haratake A., Uchida Y., Mimura K., Elias P. M., Holleran W. M., J. Invest. Dermatol., 108, 319-323 (1997).
24. Baba T., Hanada K,, Hashimoto I., J. Dermatol. Sci., 12, 18-23 (1996).
25. Houben E., Paepe K. De., Rogiers V., Skin Pharmacol. Physiol., 20, 122-132 (2007).
26. Uchida Y., Nardo A. D., Collins V., Elias P. M., Holleran W. M., J. Invest. Dermatol., 120, 662-669 (2003).